Used as a potent and selective antagonist of the 5-HT6 receptor, this compound is primarily investigated for its potential in treating central nervous system disorders. It shows promise in improving cognitive function and memory, making it a candidate for Alzheimer's disease research. The compound crosses the blood-brain barrier effectively, enhancing its neuroactive profile. It has also been studied for effects on obesity and eating disorders due to the role of 5-HT6 receptors in regulating appetite and metabolism. Its structural design allows for high binding affinity and selectivity, reducing off-target effects in pharmacological applications.